Dandan Wang

2.2k total citations
62 papers, 1.8k citations indexed

About

Dandan Wang is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Dandan Wang has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cancer Research, 38 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Dandan Wang's work include MicroRNA in disease regulation (32 papers), Circular RNAs in diseases (22 papers) and Cancer-related molecular mechanisms research (19 papers). Dandan Wang is often cited by papers focused on MicroRNA in disease regulation (32 papers), Circular RNAs in diseases (22 papers) and Cancer-related molecular mechanisms research (19 papers). Dandan Wang collaborates with scholars based in China, United States and Germany. Dandan Wang's co-authors include Jinhai Tang, Su‐Jin Yang, Shanliang Zhong, Hongyu Shen, Jianhua Zhao, Xiu Chen, Huanhuan Sha, Liangpeng Li, Li Ding and Dali Yan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Dandan Wang

53 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dandan Wang China 29 1.2k 1.1k 190 120 120 62 1.8k
Jong Kook Park South Korea 23 1.4k 1.1× 1.2k 1.1× 392 2.1× 93 0.8× 104 0.9× 70 2.1k
Feng Jiang China 25 1.2k 1.0× 597 0.6× 198 1.0× 123 1.0× 244 2.0× 70 1.7k
Xianyue Ren China 24 1.1k 0.9× 636 0.6× 252 1.3× 82 0.7× 146 1.2× 56 1.6k
Jing Huang China 23 934 0.8× 634 0.6× 412 2.2× 160 1.3× 117 1.0× 81 1.6k
Sheng Tan China 26 1.1k 0.9× 791 0.7× 238 1.3× 82 0.7× 75 0.6× 55 1.5k
Yugang Wang China 24 1.1k 0.9× 680 0.6× 307 1.6× 125 1.0× 231 1.9× 43 1.8k
Xiang Da Dong United States 23 956 0.8× 635 0.6× 303 1.6× 157 1.3× 225 1.9× 69 1.7k

Countries citing papers authored by Dandan Wang

Since Specialization
Citations

This map shows the geographic impact of Dandan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Wang more than expected).

Fields of papers citing papers by Dandan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dandan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Wang. The network helps show where Dandan Wang may publish in the future.

Co-authorship network of co-authors of Dandan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dandan Wang. A scholar is included among the top collaborators of Dandan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dandan Wang. Dandan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Junchao, Yijun Lü, Dandan Wang, et al.. (2025). Nanosensitizer for enhanced radiotherapy via tumor microenvironment reshaping and ROS amplification. Theranostics. 16(3). 1577–1593.
2.
Li, Yue, Jie Zhou, Xin Liu, et al.. (2025). Exosomal miR-122-5p for regulation of secretory functions of fibroblasts and promotion of breast cancer metastasis by targeting MKP-2: an experimental study. Cancer Biology & Therapy. 26(1). 2500104–2500104. 1 indexed citations
3.
4.
5.
Takemoto, Kenji, Jian Zhao, Xue Xu, et al.. (2024). Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages. Annals of the Rheumatic Diseases. 84(2). 294–306. 2 indexed citations
6.
Wang, Dandan, Shujie Zhang, Xin Wen, et al.. (2023). Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1. Journal of Immunology Research. 2023. 1–14. 6 indexed citations
7.
Li, Li, Xiaofei Ma, Dandan Wang, et al.. (2022). Notch1 signaling contributes to TLR4-triggered NF-κB activation in macrophages. Pathology - Research and Practice. 234. 153894–153894. 18 indexed citations
8.
Zhang, Linhan, Sheng Zhao, Huijie Jiang, et al.. (2022). Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer. EJNMMI Research. 12(1). 70–70. 3 indexed citations
9.
Wang, Dandan, et al.. (2022). Impact of adequate lymph nodes dissection on survival in patients with stage I rectal cancer. Frontiers in Oncology. 12. 985324–985324.
10.
11.
Wang, Dandan, et al.. (2022). Blood retinol and retinol-binding protein concentrations are associated with diabetes: a systematic review and meta-analysis of observational studies. European Journal of Nutrition. 61(7). 3315–3326. 6 indexed citations
12.
Cheng, Yuan, Dandan Wang, Feng Wang, et al.. (2020). Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes. Journal of the American Society of Nephrology. 31(7). 1539–1554. 70 indexed citations
13.
Yang, Jian, et al.. (2019). MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer. Yonsei Medical Journal. 60(5). 414–414. 10 indexed citations
14.
Wang, Jinyan, Qian Zhang, Dandan Wang, et al.. (2017). MiR-29a : a potential therapeutic target and promising biomarker in tumors. Bioscience Reports. 38(1). 55 indexed citations
15.
Yang, Fan, Jiaji Ding, Dali Yan, et al.. (2016). MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Gene. 594(1). 47–58. 57 indexed citations
16.
Shen, Hongyu, Liangpeng Li, Su‐Jin Yang, et al.. (2016). MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway. Gene. 593(1). 84–90. 70 indexed citations
17.
Wang, Dandan, Jian Li, Huanhuan Sha, et al.. (2016). miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression. Gene. 590(1). 44–50. 22 indexed citations
18.
Shen, Hongyu, Dandan Wang, Liangpeng Li, et al.. (2016). MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway. Gene. 596. 110–118. 83 indexed citations
19.
Chen, Xiu, Peng Lü, Ying Wu, et al.. (2016). MiRNAs-mediated cisplatin resistance in breast cancer. Tumor Biology. 37(10). 12905–12913. 24 indexed citations
20.
Chen, Xiu, Shanliang Zhong, Peng Lü, et al.. (2016). miR-4443 Participates in the Malignancy of Breast Cancer. PLoS ONE. 11(8). e0160780–e0160780. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong Kook Park Breakdown of academic impact, for papers by Feng Jiang Breakdown of academic impact, for papers by Xianyue Ren Breakdown of academic impact, for papers by Jing Huang Breakdown of academic impact, for papers by Sheng Tan Breakdown of academic impact, for papers by Yugang Wang Breakdown of academic impact, for papers by Xiang Da Dong
Rankless by CCL
2026